One of our writers wrote an article today about a brand new test for HER2, which is being revealed today at the San Antonio Breast Cancer Symposium. It's a completely new way of testing by gene expression profiling and can radically alter treatment recommendations.
We don't have a vested interest in the company that is coming out with the test, we just got early news of the announcement and are trying to spread the word. We thought your readers might be interested: